2268.HK · WUXI XDC
Hong Kong · RS rating 87 · As of 2026-10-14
| Price | 77.05 HKD |
|---|---|
| 1-day change | -3.2% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 70 / 89 / 61 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 47 / 53 / 42 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +8.5% |
| Market cap (USD) | $13.2B |